• Listed Companies
  • Announcements
  • TIANJIN DEV
  • EN
  • 繁
  • 简
  • Sep 17, 2025
    20:23

    Announcement Pursuant to Rule 13.18 of the Listing Rules

    Loan Agreement with Specific Performance Covenant

    00882 - TIANJIN DEV


  • Sep 10, 2025
    19:26

    Discloseable and Connected Transaction - Formation of Fund

    Connected Transaction

    00882 - TIANJIN DEV


  • Sep 10, 2025
    17:00

    Discloseable Transaction - Subscription of Wealth Management Product with Industrial Bank

    Discloseable Transaction

    00882 - TIANJIN DEV


  • Aug 28, 2025
    17:47

    Interim Dividend for the six months ended 30 June 2025

    Dividend or Distribution (Announcement Form)

    00882 - TIANJIN DEV


  • Aug 28, 2025
    17:43

    Announcement of Interim Results for the six months ended 30 June 2025

    Closure of Books or Change of Book Closure Period

    00882 - TIANJIN DEV


  • Aug 22, 2025
    12:01

    Unaudited Financial Results for the six months ended 30 June 2025 of Tianjin Lisheng Pharmaceutical Co., Ltd.

    Results of a Subsidiary

    00882 - TIANJIN DEV


  • Aug 22, 2025
    06:10

    Potential Discloseable and Connected Transaction - Formation of Fund

    Inside Information

    00882 - TIANJIN DEV


  • Aug 18, 2025
    12:03

    Date of Board Meeting

    Date of Board Meeting

    00882 - TIANJIN DEV


  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 58
  • 59
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2025 All right reserved.